What should you know about mRNA cancer vaccines?

Unlike a routine preventive vaccine, a cancer vaccine may be therapeutic: it is used alongside cancer care to stimulate immune cells against features found on a tumour. Some approaches use information from a person’s tumour to design the mRNA instructions, while others target features shared by a group of cancers. The treatment may be studied or offered only in selected settings, and it does not replace surgery, chemotherapy, radiotherapy, immunotherapy, or monitoring unless the oncology team advises that plan.

Ask the oncology team whether a vaccine is relevant to your cancer type, stage, tumour testing, and current treatment. Discuss timing around surgery, chemotherapy, radiotherapy, or other immune treatments. Tell the team about allergies, autoimmune disease, pregnancy, infections, and medicines. Keep a record of fever, injection-site changes, fatigue, or other symptoms after treatment so the team can judge whether they are expected or need attention.

Contact the oncology service urgently for a high fever, shaking chills, confusion, severe weakness, or signs of infection. Emergency help is needed for breathing difficulty, facial or throat swelling, collapse, or severe chest pain. Cancer treatment can also affect blood counts and immune activity, so do not wait for a routine appointment when your team has given a specific emergency number or symptom plan.

Ask what target the vaccine addresses, whether tumour testing is needed, what benefit the team is seeking, how it fits with your existing treatment, and how side effects will be monitored. Ask whether the option is available through routine care or a supervised clinical programme.